Vous avez cherché: iop (Anglais - Maltais)

effect on intraocular pressure (iop)
effett fuq il-pressjoni intraokulari (iop)

timolol lowers iop by reducing aqueous humour formation.
timolol inaqqas l-iop billi jnaqqas il-formazzjoni ta’ aqueous humour.

the iop-lowering effect of brimonidine may be longer.
l-effett li jbaxxi l-iop ta’ brimonidine jista’ jkun itwal.

no patient required removal of the implant by vitrectomy to control iop.
l-ebda pazjent ma kien jeħtieġ it-tneħħija tal- impjant permezz ta’ vitrektomija biex tiġi kkontrollata l-iop.

table 3: iop change from baseline (mmhg) for izba
tabella 3: bidla fl-iop mil-linja bażi (mmhg) għal izba

existing data suggest that evening dosing might have some advantages in the mean iop reduction.
tagħrif eżistenti jissuġġerixxi li l-għoti filgħaxija jista’ jkollu xi vantaġġi fil-medja tat-tnaqqis tal-iop.

caution should be utilised in treating these patients and close monitoring of iop is recommended.
għandu jkun hemm attenzjoni meta jiġu kkurati dawn il-pazjenti u hija rrakkomandata sorveljanza mill-qrib ta’ l-iop.

existing literature data for ganfort suggest that evening dosing may be more effective in iop lowering than morning dosing.
dejta minn letteratura eżistenti għal ganfort tissuġġerixxi li dożaġġ filgħaxija jista’ jkun iktar effettiv f’li jbaxxi l-iop minn dożaġġ filgħodu.

azarga is used when treatment with a medicine containing only one active substance has been tried but has not reduced the iop sufficiently.
azarga jintuża meta jkun ġie ppruvat trattament b’mediċina li jkun fiha biss sustanza attiva waħda iżda li ma jkunx naqqas l-iop biżżejjed.

these two components decrease elevated iop primarily by reducing aqueous humour secretion, but do so by different mechanisms of action.
dawn iż-żewġ komponenti jnaqqsu l-pressjoni elevata ġewwa l-għajn l-aktar billi jnaqqsu s-sekrezzjoni ta’ l-aqueous humour iżda jagħmlu hekk b’mekkaniżmi ta’ azzjoni differenti.

in the second study, iop had fallen from around 26 mmhg by around 8.3 mmhg after six months in both groups of patients.
fit-tieni studju, l-iop kien naqas minn madwar 26 mmhg b’madwar 8.3 mmhg wara sitt xhur fiż-żewġ gruppi ta’ pazjenti.

a total of 4 patients (1%) treated with ozurdex had procedures in the study eye for the treatment of iop elevation.
total ta’ 4 pazjenti (1%) ikkurati b’ozurdex kellhom proċeduri fil-għajn li ġiet studjata għall-kura ta’ żieda fl-iop.

as expected with ocular steroid treatment and intravitreal injections, increases in intraocular pressure (iop) may be seen.
kif mistenni b’kura okulari bi sterojdi u injezzjonijiet ġol-vitriju, jistgħu jiġu osservati żidiet fil-pressjoni ġol-għajnejn (iop).

some patients were naive to iop therapy whilst others were on other iop-lowering medicinal product(s).
xi wħud mill-pazjenti ma’ kienu fuq l-ebda terapija waqt li oħrajn kienu qed jieħdu xi prodott(i) mediċinali oħra biex titbaxxa l-pressjoni tal-għajnejn.